Baxter suffers loss in contaminated heparin case; Caraco delisted, merges with Sun;

> Baxter International has lost the first case in its ongoing legal dispute over the 2007-2008 heparin contamination. Item

> Quality-challenged Caraco Pharmaceutical Laboratories in Detroit has been removed from the New York Stock Exchange after voting to become a private company and merge with majority shareholders Sun Pharmaceutical Industries, Sun Pharma Global and Sun Laboratories Inc. Story

> There were 1,693 known incidents of counterfeit medicines last year, a rise of 7% over the 2009 figure. News

> GlaxoSmithKline plans to hire about 30 new employees at its Hamilton facility due to demand for its cervical cancer vaccine. Story

> West Pharmaceutical Services has begun construction on a compression molding plant in the Shanghai Qingpu Industrial Zone adjacent to the company's injection molding facility. West release

> The Healthcare Industry Group of professional service provider Alvarez & Marsal has allied with consultancy Rondaxe to provide manufacturing, supply chain and compliance services to drugmakers. Alvarez & Marsal release

> Cardinal Health has signed a three-year agreement with pharmacy benefit manager Prime Therapeutics to continue servicing its PrimeMail mail-service pharmacy. Cardinal Health/Prime announcement

> The six key challenges to safety risk management stem from data, communication, organization, talent, money and strategy. Interview (reg. req.)

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.